Biotech Target N V - Sep 28, 2021 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role: 10%+ Owner
Signature: /s/ Daniel Koller
Stock symbol: MGNX
Transactions as of: Sep 28, 2021
Transactions value $: $4,111,420
Form type: 4
Date filed: 9/30/2021, 03:09 PM
Previous filing: Sep 24, 2021
Next filing: Oct 1, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MGNX	Common Stock	Purchase	$2.06M	+100K	+1.45%	$20.64	6.98M	Sep 28, 2021	Direct
transaction	MGNX	Common Stock	Purchase	$2.05M	+100K	+1.43%	$20.47	7.08M	Sep 29, 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Macrogenics, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.